Ingersoll Rand CapEx decreased by 3.2% to $36.30M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 7.7%, from $33.70M to $36.30M. Over 4 years (FY 2021 to FY 2025), CapEx shows an upward trend with a 20.6% CAGR.
An increase often signals growth initiatives and capacity expansion, while a decrease may suggest cost-cutting or a shift toward asset-light strategies.
This metric measures the cash outflows used to acquire, upgrade, and maintain physical assets such as property, building...
Commonly compared as a percentage of revenue; capital-intensive firms like Abbott require consistent investment to remain competitive in medical technology.
capital_expenditures| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $11.60M | $15.30M | $22.90M | $17.90M | $21.40M | $21.80M | $33.50M | $22.40M | $24.80M | $28.60M | $29.60M | $62.30M | $21.80M | $29.70M | $35.30M | $33.70M | $35.30M | $29.10M | $37.50M | $36.30M |
| QoQ Change | — | +31.9% | +49.7% | -21.8% | +19.6% | +1.9% | +53.7% | -33.1% | +10.7% | +15.3% | +3.5% | +110.5% | -65.0% | +36.2% | +18.9% | -4.5% | +4.7% | -17.6% | +28.9% | -3.2% |
| YoY Change | — | — | — | — | +84.5% | +42.5% | +46.3% | +25.1% | +15.9% | +31.2% | -11.6% | +178.1% | -12.1% | +3.8% | +19.3% | -45.9% | +61.9% | -2.0% | +6.2% | +7.7% |
| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Industrial Technologies and Services | $15.10M | $19.70M | $28.00M | $26.40M | $17.10M | $20.60M | $28.40M | $29.80M |
| Precision and Science Technologies | $3.00M | $7.20M | $5.80M | $6.90M | $14.60M | $7.50M | $7.90M | $6.20M |
| Total | $21.80M | $29.70M | $35.30M | $33.70M | $35.30M | $29.10M | $37.50M | $36.30M |